Cargando…
Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells
Autores principales: | Bergmann, Christina, Müller, Fabian, Distler, Jörg H W, Györfi, Andrea-Hermina, Völkl, Simon, Aigner, Michael, Kretschmann, Sascha, Reimann, Hannah, Harrer, Thomas, Bayerl, Nadine, Boeltz, Sebastian, Wirsching, Andreas, Taubmann, Jule, Rösler, Wolf, Spriewald, Bernd, Wacker, Jochen, Atzinger, Armin, Uder, Michael, Kuwert, Torsten, Mackensen, Andreas, Schett, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359520/ https://www.ncbi.nlm.nih.gov/pubmed/37147112 http://dx.doi.org/10.1136/ard-2023-223952 |
Ejemplares similares
-
Assessment of myocardial fibrosis in patients with systemic sclerosis using [(68)Ga]Ga-FAPI-04-PET-CT
por: Treutlein, Christoph, et al.
Publicado: (2022) -
Role of CAR T Cell Metabolism for Therapeutic Efficacy
por: Rial Saborido, Judit, et al.
Publicado: (2022) -
Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy
por: Reimann, Hannah, et al.
Publicado: (2022) -
Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy
por: Nunez, Daniel, et al.
Publicado: (2023) -
Neutralizing monoclonal antibodies against SARS-CoV-2 for COVID-19 pneumonia in a rituximab treated patient with systemic sclerosis—A case report and literature review
por: Yalcin Mutlu, Melek, et al.
Publicado: (2022)